The maintenance of healthy peri-implant tissues is essential for the longevity of dental implants (Renvert & Quirynen 2015) . Changes in peri-implant hard and soft tissues as well as restorative and patient-based subjective measures are the most widely used parameters for evaluating the outcomes of implant therapy (Papaspyridakos et al. 2012) . Marginal bone levels are expected to become stable by the first year of functional loading, and, after this, an annual crestal bone loss (CBL) of more than 0.2 mm is regarded as undesirable (Albrektsson et al. 1986; Misch et al. 2008) . However, 1.5-2 mm CBL in the first year might be an acceptable outcome according to several studies as it may be considered a physiological process (Tarnow et al. 2000; Roos-Jansaker et al. 2006; Papaspyridakos et al. 2012) .
Crestal bone loss can be physiological or pathological in nature (Tatarakis et al. 2012) and may be influenced by multiple factors (Albrektsson et al. 2012a,b) . Some variables that might affect CBL are surgical trauma (Qian et al. 2012) , implant positioning (van Eekeren et al. 2015) , implant design (Canullo et al. 2010) , implant diameter (Petrie & Williams 2005) , abutment height (GalindoMoreno et al. 2015) , implant-abutment connection type (Schwarz et al. 2014) , prosthetic design (Cardaropoli et al. 2006) , the presence of pathogenic microflora (Lindhe & Meyle 2008) and smoking (Galindo-Moreno et al. 2005) .
The results of a recent preclinical study reported that a thin mucosa at the time of implant installation resulted in the establishment of a "biologic width" related CBL during wound healing (Baffone et al. 2013) . In natural teeth, the average biologic width (from the base of the sulcus to the alveolar bone margin) was found to be 2.04 mm, of which 0.97 mm was epithelial attachment and 1.07 mm was connective tissue attachment (Gargiulo et al. 1961) . In implants, it was first described as the dimension between the first bone-to-implant contact and the apical extension of the junctional epithelium around non-submerged, one-piece dental implants (Cochran et al. 1997) . Transmucosal attachment surrounding implants seems to be established either at the time of wound healing following implant placement or at abutment connection (Lindhe et al. 2015) ; the mechanism involves epithelial proliferation followed by collagen fiber organization and may take several weeks to be completed (Berglundh et al. 2007; H€ ammerle & Giannobile 2014 ). This attachment is called "biologic width" and serves as a seal responsible for the protection of peri-implant hard tissues (Cochran et al. 1997; Berglundh et al. 2007) . The maintenance of a healthy and unviolated biologic width around implants is crucial for long-term success (Berglundh et al. 1991; Hermann et al. 2000) . However, there is controversy in the literature about the height of peri-implant mucosa that could be considered as adequate to form biologic width around implants.
Peri-implant soft tissue thickness, or soft tissue biotype, is mostly referred to as thin or thick, even though it has been reported that a majority of soft tissues might be of mixed pattern (M€ uller et al. 2000; M€ uller & K€ on€ onen 2005) with individual variations (Kan et al. 2003) .
The aim of this systematic review and metaanalysis is to investigate the relation between peri-implant soft tissue thickness and CBL.
Material and methods
The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement (Moher et al. 2009 ) was followed.
Focused question
The question addressed was the following: "What are the differences in clinical outcome in terms of CBL between implants placed in sites with initial soft tissue thickness <2 mm and those with ≥2 mm?"
Types of studies
Prospective clinical studies assessing CBL around implants placed in subjects with thin or thick biotype were considered. Only studies with at least ten patients per group were selected, to exclude individual case reports.
Populations of studies
Systemically healthy subjects who received dental implants a minimum of 4 months after tooth extraction were included.
Intervention
Following an initial baseline evaluation of mucosal tissue biotype, patients were divided into thin biotype group (<2 mm; test group) and thick biotype group (≥2 mm; control group).
Patients received dental implants with late implantation, standard loading protocol and fixed restorations. No restriction related to the flap technique (flap/flapless), implant design (internal/external/conical) and surgical stage (one/two stage) was initially applied to avoid omitting relevant data. However, soft tissue augmentation for increasing soft tissue thickness was an exclusion criterion.
Comparison
The differences in clinical outcome in terms of radiographic CBL between implants placed in sites with thin biotype (<2 mm) and thick biotype (≥2 mm) were analyzed.
Outcome
The primary outcome of this review was the radiographic CBL 12-month after implant loading. Secondary outcomes considered were the changes in vestibular soft tissue dimension and in papillary height as well as implant survival and/or success rates. 
Search methods for identification of studies

Screening methods
All three-stage screening (titles, abstract and full text) were carried out in duplicate and independently by two reviewers (AA and CS). Irrelevant records were excluded in these stages ( Fig. 1) . Full text of possibly eligible studies was reviewed, and any disagreement was resolved by discussion and, if necessary, a third reviewer (ATE) was consulted.
Data extraction
At the stage of full-text screening, a data extraction form was completed to check eligibility of the studies and, if eligible, to collect detailed information about population, intervention and outcomes. For each selected study, the following data were extracted: details of study and population characteristics, methodology and statistics, intervention characteristics and outcomes. If any data were missing or incomplete, the authors were contacted via email allowing a period of 4 weeks to reply. Author responses and reasons for study exclusion were recorded (Table 2) .
Quality assessment
The risk of bias assessment of the included trials was assessed independently and in duplicate by at least two review authors (AA, CS, ATE) as part of the data extraction process. This was conducted using the Cochrane Collaboration's tool for assessing risk of bias (Higgins & Green 2011) . This is a two-part tool, addressing the six specific domains (namely sequence generation, allocation concealment, blind outcome assessment, incomplete outcome data, selective outcome reporting and "other issues") and each domain includes one specific entry in a "risk of bias" 
Statistical analysis
Meta-analysis was carried out for both continuous and dichotomous measures with the statistical software MedCalc 15.8 (MedCalc Software bvba, Ostend, Belgium). The statistical unit was the patient. Under the fixed-effects model, it is assumed that all studies come from a common population and that the effect size (standardized mean difference equal to the difference in means divided by the pooled standard deviation) is similar among the different trials. This assumption was tested by the "heterogeneity test" and by consideration of the I 2 statistic, which represents the percentage of the total variation across studies due to heterogeneity. Due to a significant heterogeneity between the studies, a random-effects model was more appropriate, in which both the random variation within the studies and the variation between the different studies are incorporated. The level of agreement between the two reviewers regarding relevant factors in the studies were determined using kappa statistics.
Results
Studies included
The initial search resulted in 2962 articles (1298 articles at MEDLINE via OV _ ID, 1607 at EMBASE, 39 articles at Cochrane Database and 18 articles at additional sources). After checking for duplicated articles, 933 articles were excluded, resulting in 2029 potentially eligible articles. Following title screening, 180 articles were selected for abstract screening, and of these, 31 full-text articles were assessed for eligibility. Six (6) articles met the defined inclusion criteria, and 25 papers were excluded (Fig. 1) . The reasons for exclusion of the studies at the level of full-text screening are reported in Table 2 . Kappa statistics showed a high level of agreement between the reviewers (K > 0.90). All the included studies had a controlled clinical trial design; two studies were split mouth (Linkevicius et al. 2009a; Linkevicius et al. 2015c ) and four were parallel design (Kaminaka et al. 2014; Linkevicius et al. 2015a,b; (Table 3) . to 85 years (Kaminaka et al. 2014; Linkevicius et al. 2015b) . In all the included trials, the operators were specialists. Five studies reported excluding smokers; the remainder (Linkevicius et al. 2009a ) did not report on smoking.
Study characteristics
Baseline soft tissue thickness was evaluated using either CBCT (Kaminaka et al. 2014) or a periodontal probe. Study groups were either "augmented" (soft tissue augmentation, which were not included in this review), thin or thick biotype. Bone-level implants were placed after flap elevation in all included studies. Only one study reported performing second-stage surgery (Kaminaka et al. 2014) .
Fixed metal-ceramic restorations were constructed either as a single (Linkevicius et al. 2015a,b; or multiple units (Linkevicius et al. 2009a (Linkevicius et al. , 2015c Kaminaka et al. 2014 ). Only Kaminaka et al. measured the CBL using CBCT (Kaminaka et al. 2014) ; the other five studies evaluated CBL with periapical radiographs. Success criteria for the implants were defined only in one study (Kaminaka et al. 2014) as there is no clinical sign of peri-implant soft tissue inflammation.
The administration time of the antibiotics varied among the studies. In four studies, patients received antibiotics before the surgery (Linkevicius et al. 2009a (Linkevicius et al. , 2015b , one postoperatively (Kaminaka et al. 2014 ) and the remainder prescribed both preoperatively and postoperatively (Linkevicius et al. 2015a ).
Study outcomes
Radiographic CBL at 12 months after implant loading was evaluated in all studies (Table 4) . Kaminaka et al. 2014 (Kaminaka et al. 2014 compared soft tissue changes around implants with different abutment connection designs and reported CBL as 1.33 AE 1.11 in thin biotype group and 0.31 AE 0.34 in thick biotype group (P < 0.001).
In 2009, a study by Linkevicius et al. reported on 10 patients that only in the thick biotype group, the CBL was 0.17 AE 0.19 (Linkevicius et al. 2009a ). Linkevicius et al.
(2015a) compared thin, thick and augmented biotypes and found that the mean CBL values were 1.65 AE 0.08 and 0.44 AE 0.06 in thin and thick biotypes, respectively (P < 0.001) (Linkevicius et al. 2015a ). In 2015, Linkevicius et al. (Linkevicius et al. 2015b ) evaluated CBL around platform-switched implants placed in thin and thick biotype and found that the mean (min-max) CBL was 1.18 (0.1-2.1) and 0.22 (0-1.1), respectively (P < 0.001). In a similar study design, CBL was reported as 1.22 AE 0.08 and 0.22 AE 0.06 (P < 0.001) . Another trial included implants placed in only thin biotype and compared different connection designs, finding a CBL of 1.43 AE 0.23 (Linkevicius et al. 2015c) .
The four studies that compared thin vs. thick biotype (Kaminaka et al. 2014; Linkevicius et al. 2015a,b; showed significantly higher CBL in thin biotype.
Meta-analysis could only be carried out with two studies (Linkevicius et al. 2015a; . One study had to be excluded due to providing only the implant as unit of analysis (Kaminaka et al. 2014 ) and the other due to not reporting standard deviations (Linkevicius et al. 2015b) . No statistically significant differences were found for CBL between thin and thick biotype (P = 0.189) using the random-effects model. A fixed-effects model was not considered statistically appropriate due to the high heterogeneity between the studies.
Regarding changes in vestibular soft tissue dimension, a mean loss in soft tissue height (measured from the implant platform to the marginal soft tissue level) of 0.31 AE 0.27 in the thin biotype group and 0.08 AE 0.06 in the thick biotype group (P < 0.001) was reported (Kaminaka et al. 2014) .
None of the studies reported changes in papillary height.
All studies reported a success and survival rate of 100% (Linkevicius et al. 2009a (Linkevicius et al. , 2015a Kaminaka et al. 2014; Risk of bias assessment of the included trials is summarized in Figs 2 and 3. None of the included studies were at low risk of bias.
Discussion
The classification of the soft tissue thickness shows high variation among different studies. Thin biotype has been described as ≤1.5 and <1.5 mm, respectively (Claffey & Shanley 1986 and Wang 2007) , or <1 to Becker et al. (2005) Baseline soft tissue thickness is not assessed Buchs et al. (1996) Baseline soft tissue thickness is not assessed Canullo et al. (2012) Baseline soft tissue thickness is not assessed Cardaropoli et al. (2006) Study population not classified according to biotype Fernandes (2011) Baseline soft tissue thickness is not assessed and no information about implant placement or loading protocol Gallucci et al. (2011) * Baseline soft tissue thickness is not assessed Jeong et al. (2011) Radiographic crestal bone loss assessment is reported 12 months after the implant placement not restoration Kan et al. (2003) No information about the implant placement protocol and radiographic crestal bone loss is not reported Kehl et al. (2011) Loading protocol is not reported and baseline soft tissue thickness is not assessed Linkevicius et al. (2009b) Insufficient number of patients Linkevicius et al. (2010) Insufficient number of patients Nisapakultorn et al. (2010) No information about implant placement or loading protocol No information about implant placement, loading protocol or type of restoration Rasner (2013) Insufficient number of patients Sanz Martin et al. (2016) Patients received guided bone regenerative procedures and removable prostheses are included in study population Takuma et al. (2014) Baseline soft tissue thickness is not assessed and radiographic crestal bone loss assessment is reported 12 months after the implant placement not restoration Tan Fully edentulous patients are included and immediate loading Vervaeke et al. (2016) Fully edentulous patients are included and immediate loading Wiesner et al. (2010) Insufficient number of patients *Author responses to e-mail contact for any missing or incomplete data.
2 mm (Chen et al. 2009 ), whereas thick biotype has been defined as from >1 to 2 mm (Chen et al. 2009 ), ≥1.5 mm (Bashutski & Wang 2007) or ≥2 mm (Claffey & Shanley 1986) . In a recent systematic review (Su arez-L opez Del Amo et al. 2016 ) and the present systematic review, thin biotype was described as <2 mm and thick as ≥2 mm. Different diagnostic methods have been used to measure soft tissue, which may in turn influence the definition of the biotype (thick or thin). Some examples of biotype assessment methods are visual recognition of the outline of the probe through the marginal tissue (Kan et al. 2003 ), a method based on an assessment of a ratio between the crown length and width (Olsson & Lindhe 1991) , ultrasonic instruments (M€ uller et al. 2000) , direct measurement with calipers or trans-gingival sounding (Frost et al. 2015) . The included studies measured baseline soft tissue thickness with either CBCT or periodontal probe prior to implant placement. Although soft tissue thickness can be measured by periodontal probe in a simple way, the measurement results in accuracy to the nearest 0.5 mm. CBCT offers a high accuracy in assessing soft tissue thickness but requires an exposure to radiation, which may not be justifiable (Zweers et al. 2014) . It has been suggested that the initial amount of soft tissue thickness may have a crucial role in the outcome of dental implant treatment (Hermann et al. 2000; Lee et al. 2011; Baffone et al. 2013; Thoma et al. 2014) . In a preclinical study, it was observed that, when the thickness of the mucosa was reduced experimentally, bone resorption took place to create biologic width (Berglundh & Lindhe 1996) . Also, an experimental study in dogs showed that increased thickness of the soft tissue reduced CBL (Bengazi et al. 2015) . Furthermore, it was reported that early bone remodeling was influenced by the initial soft tissue thickness in edentulous patients with two non-splinted implants supporting an overdenture (Vervaeke et al. 2014 ). According to the results of a recent metaanalysis (Su arez-L opez Del Amo et al. 2016), the weighted mean difference between thick and thin biotype was reported as À0.80 mm (95% CI = À1.18 mm to À0.42 mm) with significantly less CBL in the thick group, when the implant was considered as the unit of analysis. The present systematic review was designed with the patient as the unit of analysis, and baseline was the time of implant loading rather than implant placement. Moreover, author responses for the missing or unpublished data were included in the current review. These differences could explain the different conclusions reached despite a similar focused question.
The primary outcome of the present systematic review was the evaluation of the radiographic CBL. Even though the periapical radiographs have been reported as an ideal method for peri-implant CBL measurement (Albrektsson et al. 2012a,b) , three-dimensional radiographic measurements could provide additional relevant information. However, only one of the six included studies used CBCT.
The type of implant and its supra-or subcrestal placement, surgical technique (flap/ flapless), type of restoration and smoking have been considered as important confounding factors on CBL (Tatarakis et al. 2012) . The implant types included in the present systematic review were bone level, and as long as they were placed in accordance with the manufacturer 0 s recommendations, implant placement depth would not have differed significantly between the included studies. Other factors such as distance between implant and adjacent teeth, or location of the implants within the jaw (adjacent to teeth or edentulous space), might have had an effect on CBL.
Although the importance of the periimplant mucosal thickness has been further emphasized, the adequate thickness (in millimeters) to preserve CBL still remains controversial.
In its intention to analyze the differences in clinical outcome between thin and thick soft tissue biotypes, this review identified only four clinical trials that directly compared CBL after delayed implant placement and standard loading protocol with fixed prostheses in these two groups with a followup of at least 12 months after loading. All of the studies were at unclear or high risk of bias, which weakens confidence in the results (Higgins & Green 2011) . A recent systematic review also reported potential bias of the selected studies (Su arez-L opez Del Amo et al. 2016) . Despite the fact that the four studies independently reported significant differences, the meta-analysis did not find statistically significant differences, most likely due to the heterogeneity between the studies. The included studies reported a 100% survival rate in both groups.
Conclusions
At present, there is insufficient amount of evidence to answer the question on the differences in clinical outcome in terms of CBL between implants placed in sites with initial soft tissue thickness <2 mm and those with ≥2 mm. Well-designed controlled clinical trials with low risk of bias are needed to analyze the effect of soft tissue thickness on the clinical outcomes of dental implants. Although it may not be possible to blind the clinicians, blinding of outcome assessors is suggested for future research. Furthermore, decreased heterogeneity and control of all the present source of bias are recommended. There is also a need to find a more reliable, objective and reproducible method to measure soft tissue thickness. Moreover, an understanding of the peri-implant mucosa in a dimensional manner and its possible variations may guide clinicians to predict critical physiological requirements and esthetic demands of the restoration. 
